RNA Targeting Small Molecule Drug Discovery Market Size, Share & Trends Report

RNA Targeting Small Molecule Drug Discovery Market Size, Share & Trends Analysis Report By Indication (Cancer, Infectious Diseases), By End-User, By Region, And Segment Forecasts, 2023 - 2030

  • Report ID: GVR-4-68040-049-3
  • Number of Pages: 120
  • Format: Electronic (PDF)
  • Historical Range: 2018 - 2021
  • Industry: Healthcare

Table of Contents

Chapter 1. Methodology and Scope
                   1.1. Market Segmentation & Scope
                       1.1.1. Segment Scope
                       1.1.2. Regional scope
                       1.1.3. Estimates and forecast timeline
                   1.2. Research Methodology
                   1.3. Information Procurement
                       1.3.1. Purchased database
                       1.3.2. GVR’s internal database
                       1.3.3. Secondary sources
                       1.3.4. Primary research
                       1.3.5. Details of primary research
                           1.3.5.1. Data for primary interviews in North America
                           1.3.5.2. Data for primary interviews in Europe
                           1.3.5.3. Data for primary interviews in Asia Pacific
                           1.3.5.4. Data for primary interviews in Latin America
                           1.3.5.5. Data for Primary interviews in MEA
                   1.4. Information or Data Analysis
                       1.4.1. Data analysis models
                   1.5. Market Formulation & Validation
                   1.6. Model Details
                   1.7. List of Secondary Sources
                   1.8. List of Primary Sources
                   1.9. Objectives
                       1.9.1. Objective 1
                       1.9.2. Objective 2
Chapter 2. Executive Summary
                   2.1. Market Outlook
Chapter 3. RNA-targeting Small Molecule Drug Discovery Market Variables, Trends & Scope
                   3.1. Market Lineage Outlook
                       3.1.1. Parent market outlook
                       3.1.2. Related/ancillary market outlook
                   3.2. Market Dynamics
                       3.2.1. Market driver analysis
                           3.2.1.1. Increasing pipeline of RNA-targeting small molecules drugs
                           3.2.1.2. Increasing private and public funding for the discovery and development of RNA-targeting small-molecule drugs
                           3.2.1.3. Growing prevalence of cancer and neurological disorders to boost the demand for novel RNA-targeting small molecules drugs
                       3.2.2. Market restraint analysis
                           3.2.2.1. High cost of drug development and the complexity of RNA-based drug discovery is expected to hinder the market growth
                           3.2.2.2. Comparatively low awareness in developing economies about RNA-targeting small molecules
                   3.3. RNA Targeting Small Molecule Drug Discovery: Market Analysis Tools
                       3.3.1. Industry Analysis - Porter’s
                           3.3.1.1. Supplier power
                           3.3.1.2. Buyer power
                           3.3.1.3. Substitution threat
                           3.3.1.4. Threat of new entrant
                           3.3.1.5. Competitive rivalry
                       3.3.2. PESTEL Analysis
                           3.3.2.1. Political landscape
                           3.3.2.2. Technological landscape
                           3.3.2.3. Economic landscape
                       3.3.3. Major Deals & Strategic Alliances Analysis
                       3.3.4. COVID-19 Impact Analysis
Chapter 4. RNA-targeting Small Molecule Drug Discovery Market: Indication Estimates &Trend Analysis
                   4.1. Definitions and Scope
                   4.2. RNA-targeting Small Molecule Drug Discovery: Indication Market Share, 2022 2030
                       4.2.1. Cancer
                           4.2.1.1. Cancer Market, 2018 - 2030 (USD Million)
                       4.2.2. Infectious Diseases
                           4.2.2.1. Infectious Diseases Market, 2018 - 2030 (USD Million)
                       4.2.3. Metabolic Diseases
                           4.2.3.1. Metabolic Diseases
                       4.2.4. Neurological Diseases
                           4.2.4.1. Neurological Disease Market, 2018 - 2030 (USD Million)
                       4.2.5. Others
                           4.2.5.1. Others Market, 2018 - 2030 (USD Million)
Chapter 5. RNA-targeting Small Molecule Drug Discovery Market: End User Segment Estimates & Trend Analysis
                   5.1. Definitions and Scope
                   5.2. RNA-targeting Small Molecule Drug Discovery Market: End-User Market Share Analysis, 2021 & 2030
                       5.2.1. Pharmaceutical and Biopharmaceutical Companies
                           5.2.1.1. Synthetic Market, 2018 - 2030 (USD Million)
                       5.2.2. Academic and Research Institutes
                           5.2.2.1. Academic and Research Institutes Market, 2018 - 2030 (USD Million)
                       5.2.3. Others
                           5.2.3.1. Others Market, 2018 - 2030 (USD Million)
Chapter 6. RNA-targeting Small Molecule Drug Discovery Market: Regional Analysis
                   6.1. Healthcare Finance Solutions: Regional market share analysis, 2021 & 2030
                   6.2. North America
                       6.2.1. North America Market estimates and forecast, 2018 - 2030
                       6.2.2. U.S.
                           6.2.2.1. U.S. Market estimates and forecast, 2018 - 2030 (USD Million)
                       6.2.3. Canada
                           6.2.3.1. Canada Market estimates and forecast, 2018 - 2030 (USD Million)
                   6.3. Europe
                       6.3.1. Europe Market estimates and forecast, 2018 - 2030
                       6.3.2. U.K.
                           6.3.2.1. U.K. Market estimates and forecast, 2018 - 2030 (USD Million)
                       6.3.3. Germany
                           6.3.3.1. Germany Market estimates and forecast, 2018 - 2030 (USD Million)
                       6.3.4. France
                           6.3.4.1. France Market estimates and forecast, 2018 - 2030 (USD Million)
                       6.3.5. Italy
                           6.3.5.1. Italy Market estimates and forecast, 2018 - 2030 (USD Million)
                       6.3.6. Spain
                           6.3.6.1. Spain Market estimates and forecast, 2018 - 2030 (USD Million)
                       6.3.7. Denmark
                           6.3.7.1. Denmark Market estimates and forecast, 2018 - 2030 (USD Million)
                       6.3.8. Sweden
                           6.3.8.1. Sweden Market estimates and forecast, 2018 - 2030 (USD Million)
                       6.3.9. Norway
                           6.3.9.1. Norway Market estimates and forecast, 2018 - 2030 (USD Million)
                   6.4. Asia Pacific
                       6.4.1. Asia Pacific Market estimates and forecast, 2018 - 2030
                       6.4.2. Japan
                           6.4.2.1. Japan Market estimates and forecast, 2018 - 2030 (USD Million)
                       6.4.3. China
                           6.4.3.1. China Market estimates and forecast, 2018 - 2030 (USD Million)
                       6.4.4. India
                           6.4.4.1. India Market estimates and forecast, 2018 - 2030 (USD Million)
                       6.4.5. Thailand
                           6.4.5.1. Thailand Market estimates and forecast, 2018 - 2030 (USD Million)
                       6.4.6. South Korea
                           6.4.6.1. South Korea Market estimates and forecast, 2018 - 2030 (USD Million)
                       6.4.7. Australia
                           6.4.7.1. Australia Market estimates and forecast, 2018 - 2030 (USD Million)
                   6.5. Latin America
                       6.5.1. Latin America Market estimates and forecast, 2018 - 2030
                       6.5.2. Brazil
                           6.5.2.1. Brazil Market estimates and forecast, 2018 - 2030 (USD Million)
                       6.5.3. Mexico
                           6.5.3.1. Mexico Market estimates and forecast, 2018 - 2030 (USD Million)
                       6.5.4. Argentina
                           6.5.4.1. Argentina Market estimates and forecast, 2018 - 2030 (USD Million)
                   6.6. MEA
                       6.6.1. South Africa
                           6.6.1.1. South Africa Market estimates and forecast, 2018 - 2030 (USD Million)
                       6.6.2. Saudi Arabia
                           6.6.2.1. Saudi Arabia Market estimates and forecast, 2018 - 2030 (USD Million)
                       6.6.3. UAE
                           6.6.3.1. UAE Market estimates and forecast, 2018 - 2030 (USD Million)
                       6.6.4. Kuwait
                           6.6.4.1. Kuwait Market estimates and forecast, 2018 - 2030 (USD Million)
Chapter 7. Competitive Landscape
                   7.1. Company Profiles
                       7.1.1. Accent Therapeutics
                           7.1.1.1. Company overview
                           7.1.1.2. Financial Performance
                           7.1.1.3. Service benchmarking
                           7.1.1.4. Strategic initiatives
                       7.1.2. Anima Biotech Inc.
                           7.1.2.1. Company overview
                           7.1.2.2. Financial performance
                           7.1.2.3. Service benchmarking
                           7.1.2.4. Strategic initiatives
                       7.1.3. Arrakis Therapeutics
                           7.1.3.1. Company overview
                           7.1.3.2. Financial performance
                           7.1.3.3. Service benchmarking
                           7.1.3.4. Strategic initiatives
                       7.1.4. AstraZeneca
                           7.1.4.1. Company overview
                           7.1.4.2. Financial performance
                           7.1.4.3. Service benchmarking
                           7.1.4.4. Strategic initiatives
                       7.1.5. Epics Therapeutics
                           7.1.5.1. Company overview
                           7.1.5.2. Financial performance
                           7.1.5.3. Service benchmarking
                           7.1.5.4. Strategic initiatives
                       7.1.6. Expansion Therapeutics
                           7.1.6.1. Company overview
                           7.1.6.2. Financial performance
                           7.1.6.3. Service benchmarking
                           7.1.6.4. Strategic initiatives
                       7.1.7. Hoffmann-La Roche Ltd
                           7.1.7.1. Company overview
                           7.1.7.2. Financial performance
                           7.1.7.3. Service benchmarking
                           7.1.7.4. Strategic initiatives
                       7.1.8. H3 Biomedicine Inc.
                           7.1.8.1. Company overview
                           7.1.8.2. Financial performance
                           7.1.8.3. Service benchmarking
                           7.1.8.4. Strategic initiatives
                       7.1.9. PTC Therapeutics.
                           7.1.9.1. Company overview
                           7.1.9.2. Financial performance
                           7.1.9.3. Service benchmarking
                           7.1.9.4. Strategic initiatives
                       7.1.10. Ribometrix
                           7.1.10.1. Company overview
                           7.1.10.2. Financial performance
                           7.1.10.3. Service benchmarking
                           7.1.10.4. Strategic initiatives
                       7.1.11. Servier Laboratories
                           7.1.11.1. Company overview
                           7.1.11.2. Financial performance
                           7.1.11.3. Service benchmarking
                           7.1.11.4. Strategic initiatives
                       7.1.12. Skyhawk Therapeutics, Inc.
                           7.1.12.1. Company overview
                           7.1.12.2. Financial performance
                           7.1.12.3. Service benchmarking
                           7.1.12.4. Strategic initiatives


List of Tables

Table 1 List of secondary sources
Table 2 List of Abbreviations


List of Figures

Fig. 1 Market research process
Fig. 2 Information procurement
Fig. 3 Market research approaches
Fig. 4 QFD modeling for market share assessment
Fig. 5 Market formulation & validation
Fig. 6 Commodity flow analysis
Fig. 7 Primary research pattern
Fig. 8 Primary interviews in North America
Fig. 9 Primary interviews in Europe
Fig. 10 Primary interviews in Asia Pacific
Fig. 11 Primary interviews in Latin America
Fig. 12 Primary interviews in MEA
Fig. 13 Market Snapshot
Fig. 14 Segment Snapshot
Fig. 15 Segment Snapshot
Fig. 16 Competitive Landscape Snapshot
Fig. 17 RNA-targeting Small Molecule Drug Discovery market segmentation
Fig. 18 Parent market outlook (2022)
Fig. 19 Related/ancillary market outlook (2022)
Fig. 20 Market driver relevance analysis (Current & future impact)
Fig. 21 Porter’s five forces analysis
Fig. 22 SWOT analysis, by a factor (political & legal, economic and technological)
Fig. 23 RNA-targeting Small Molecule Drug Discovery market indication outlook: Segment dashboard
Fig. 24 RNA-targeting Small Molecule Drug Discovery market: indication movement analysis
Fig. 25 Cancer market, 2018 - 2030 (USD Million)
Fig. 26 Infectious Diseases market, 2018 - 2030 (USD Million)
Fig. 27 Metabolic Diseases market, 2018 - 2030 (USD Million)
Fig. 28 Neurological Diseases market, 2018 - 2030 (USD Million)
Fig. 29 Others market, 2018 - 2030 (USD Million)
Fig. 30 RNA-targeting Small Molecule Drug Discovery market End User outlook: Segment dashboard
Fig. 31 Pharmaceutical and Biopharmaceutical Companies market, 2018 - 2030 (USD Million)
Fig. 32 Academic and Research Institutes market, 2018 - 2030 (USD Million)
Fig. 33 Others market, 2018 - 2030 (USD Million)
Fig. 34 Regional marketplace: Segment dashboard
Fig. 35 Regional outlook, 2022 & 2030
Fig. 36 North America market, 2018 - 2030 (USD Million)
Fig. 37 U.S. market, 2018 - 2030 (USD Million)
Fig. 38 Canada market, 2018 - 2030 (USD Million)
Fig. 39 Europe market, 2018 - 2030 (USD Million)
Fig. 40 Germany market, 2018 - 2030 (USD Million)
Fig. 41 U.K. market, 2018 - 2030 (USD Million)
Fig. 42 France market, 2018 - 2030 (USD Million)
Fig. 43 Italy market, 2018 - 2030 (USD Million)
Fig. 44 Spain market, 2018 - 2030 (USD Million)
Fig. 45 Denmark market, 2018 - 2030(USD Million)
Fig. 46 Sweden market, 2018 - 2030 (USD Million)
Fig. 47 Norway market, 2018 - 2030 (USD Million)
Fig. 48 Asia Pacific market, 2018 - 2030 (USD Million)
Fig. 49 China market, 2018 - 2030 (USD Million)
Fig. 50 Japan market, 2018 - 2030 (USD Million)
Fig. 51 India market, 2018 - 2030 (USD Million)
Fig. 52 Australia market, 2018 - 2030 (USD Million)
Fig. 53 South Korea market, 2018 - 2030 (USD Million)
Fig. 54 Latin America market, 2018 - 2030 (USD Million)
Fig. 55 Brazil market, 2018 - 2030 (USD Million)
Fig. 56 Mexico market, 2018 - 2030 (USD Million)
Fig. 57 Argentina market, 2018 - 2030 (USD Million)
Fig. 58 MEA market, 2018 - 2030 (USD Million)
Fig. 59 South Africa market, 2018 - 2030 (USD Million)
Fig. 60 Saudi Arabia market, 2018 - 2030 (USD Million)
Fig. 61 UAE market, 2018 - 2030 (USD Million)
Fig. 62 Kuwait market, 2018 - 2030 (USD Million)

What questions do you have? Get quick response from our industry experts. Request a Free Consultation
pdf

GET A FREE SAMPLE

bck

This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.

cog

NEED A CUSTOM REPORT?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities.

Contact us now to get our best pricing.

esomar icon

ESOMAR certified & member

ISO

ISO Certified

We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure. For more details, please read our privacy policy.

great place to work icon